The expression of p18(INK4) and p27(kip1) cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation

Journal of Immunology

Volumn 165, Issue 8, 2000, Pages 4346-4352

  Schrantz, N ^a   Beney, G E ^a   Auffredou, M T ^a   Bourgeade, M F ^a   Leca, G ^a   Vazquez, A ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D3; CYCLIN DEPENDENT KINASE INHIBITOR; GLYCOPROTEIN GP 39; INTERLEUKIN 10; INTERLEUKIN 2; PROTEIN P18; PROTEIN P27; UNCLASSIFIED DRUG; CARRIER PROTEIN; CD40 ANTIGEN; CDK6 PROTEIN, HUMAN; CDKN2C PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2C; CYCLINE; ENZYME INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN SERINE THREONINE KINASE; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; B CELL LEUKEMIA; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; DOWN REGULATION; DRUG ANTAGONISM; ENZYMOLOGY; IMMUNOLOGY; MACROMOLECULE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; UPREGULATION;

ANTIGENS, CD40; B-LYMPHOCYTES; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DOWN-REGULATION; ENZYME INHIBITORS; G1 PHASE; HUMANS; LEUKEMIA, B-CELL; LYMPHOCYTE ACTIVATION; MACROMOLECULAR SUBSTANCES; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 0034666845     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.8.4346     Document Type: Article

References (48)

1. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF)
2. Lymphocyte responses and cytokines
3. Principles of CDK regulation
4. CDKs and cyclins in transition(s)
5. 2 phases of the cell cycle and associates with cyclin A
6. 1-S phase protein kinase
7. 1 cyclins
8. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins
9. Physical interaction of the retinoblastoma protein with human D cyclins
10. TGF β inhibition of Cdk4 synthesis is linked to cell cycle arrest
11. 1 cell cycle stage following delivery of complete versus partial activation stimuli
12. Modulation of the p27Kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation
13. A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2-, IL-4-, or IL-10-mediated human B cell proliferation
14. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation
15. 1 cyclin-dependent kinases
16. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
17. 1 cyclin-dependent kinases
18. p21 is a universal inhibitor of cyclin kinases
19. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
20. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function
21. Cloning of p27(Kip1), a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
22. 1 cyclin-Cdk protein kinase activity, is related to p21
23. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6
24. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution
25. p57(KIP2), a structurally distinct member of the p21(CIP1) Cdk inhibitor family, is a candidate tumor suppressor gene
26. 1 checkpoint control
27. Role of the INK4a locus in tumor suppression and cell mortality
28. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
29. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)
30. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
31. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis
32. Interleukin-2-mediated elimination of the p27(Kip1) cyclin-dependent kinase inhibitor prevented by rapamycin
33. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes
34. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation
35. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development
36. Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index
37. Localization and expression of p27(KIP1) in multistage colorectal carcinogenesis
38. Characterization of transforming growth factor-β1 induced apoptosis in normal human B cells and lymphoma B cell lines
39. Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus
40. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
41. Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4
42. Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4
43. Cell cycle kinetics model of LPS-stimulated spleen cells correlates switch region rearrangements with S phase
44. Surface Ig isotypes on cells responding to lipopolysaccharide by IgM and IgG secretion
45. Modulation of E2F complexes during Go to S phase transition in human primary B-lymphocytes
46. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6
47. Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis
48. Mitochondrial regulation of cell death: Mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death